Cardiff headquartered Asalus Medical Instruments is set to rapidly launch its revolutionary new technology UltravisionTM across Europe after signing a network of exclusive distributors.
Five months after being awarded the CE mark, agreements have been established with seven distributors to supply the laparoscopic surgical smoke handling system to hospitals in the UK, Germany, France, Italy, Sweden, Denmark, Norway, Austria, Switzerland, the Benelux countries and Ireland.
Elemental Healthcare has the exclusive rights to distribute in the UK, excluding Ireland; Ecomed will cover the Benelux countries and France; Eurosurgical will distribute to Ireland; Euroclone will cover Italy; DACH in Austria and Switzerland; Kebomed in Denmark, Norway and Sweden; and LAMED will distribute it in Germany.
The first product to be launched by Asalus, which was established to commercialise the inventions of the Welsh Institute of Minimal Access Therapy (WIMAT), Ultravision is a highly innovative means of handling the surgical smoke that is created by cutting instruments during laparoscopic surgery.
Conceived by Dr Neil Warren, a specialist at the forefront of minimally invasive surgery training, Ultravision secured the CE mark in January 2014, allowing hospitals to use the system on patients undergoing laparoscopic surgery in the European Union member states.
The technology has already been met with great acclaim and won the prestigious Royal College of Surgeons’ Cutlers’ Prize for the best surgical innovation in March 2014.
Commenting on the agreements Dominic Griffiths, Managing Director of Asalus, said “With approximately six million laparoscopic procedures performed each year globally, we are confident that there is a huge market for Ultravision.
“We are already receiving overwhelming interest from the surgical community. It is exciting to now have a network of distributors on board to help us launch the technology across Europe. Within nine months of CE marking, we can now offer Ultravision to approximately 40 percent of the European population.
“The distributors we have secured all have an excellent and established reputation for developing markets for innovative devices so we are delighted to have formed these partnerships and look forward to seeing how the surgical community takes advantage of this Welsh-designed technology.”